跳转至内容
Merck
CN
  • Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141.

Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141.

Bioorganic & medicinal chemistry letters (2007-06-05)
Neeraj Garg, Yi-Lin Li, Ana Maria Garcia Collazo, Chris Litten, Denis E Ryono, Minsheng Zhang, Yolanda Caringal, Robert P Brigance, Wei Meng, William N Washburn, Peter Agback, Karin Mellström, Stefan Rehnmark, Mahmoud Rahimi-Ghadim, Thomas Norin, Marlena Grynfarb, Johnny Sandberg, Gary Grover, Johan Malm
摘要

Based on the scaffold of the pharmacologically selective thyromimetic 2b, structurally a close analog to KB-141 (2a), a number of novel N-acylated-alpha-amino acid derivatives were synthesized and tested in a TR radioligand binding assay as well as in a reporter cell assay. On the basis of TRbeta(1)-isoform selectivity and affinity, as well as affinity to the reporter cell assay, 3d was selected for further studies in the cholesterol-fed rat model. In this model 3d revealed an improved therapeutic window between cholesterol and TSH lowering but decreased margins versus tachycardia compared with 2a.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
3,3′,5-三碘代-L-甲状腺原氨酸, ≥95% (HPLC), powder